{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:58:11Z","timestamp":1790614691709,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"DOI":"10.1007\/s11701-026-04003-2","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:06:16Z","timestamp":1790564776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phase-specific workflow maturation during early institutional implementation of Aquablation for benign prostatic hyperplasia: a retrospective single-center study"],"prefix":"10.1007","volume":"20","author":[{"given":"Hsu-Cheng","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Chuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Che","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Huan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"4003_CR1","doi-asserted-by":"publisher","first-page":"13546","DOI":"10.1038\/srep13546","volume":"5","author":"W Wang","year":"2015","unstructured":"Wang W, Guo Y, Zhang D et al (2015) The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys. Sci Rep 5:13546. https:\/\/doi.org\/10.1038\/srep13546","journal-title":"Sci Rep"},{"key":"4003_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P et al (2024) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA Guideline Amendment 2023. J Urol 211:11\u201319. https:\/\/doi.org\/10.1097\/JU.0000000000003698","journal-title":"J Urol"},{"key":"4003_CR3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","volume":"199","author":"P Gilling","year":"2018","unstructured":"Gilling P, Barber N, Bidair M et al (2018) WATER: a double-blind, randomized, controlled trial of Aquablation versus transurethral resection of the prostate in benign prostatic hyperplasia. J Urol 199:1252\u20131261. https:\/\/doi.org\/10.1016\/j.juro.2017.12.065","journal-title":"J Urol"},{"issue":"Suppl 2","key":"4003_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1089\/end.2022.0439","volume":"36","author":"KC Zorn","year":"2022","unstructured":"Zorn KC, Elterman D, Gonzalez R et al (2022) Aquablation treatment for benign prostate hyperplasia: current standardized procedure. J Endourol 36(Suppl 2):S1\u2013S5. https:\/\/doi.org\/10.1089\/end.2022.0439","journal-title":"J Endourol"},{"key":"4003_CR5","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/bju.13358","volume":"117","author":"P Gilling","year":"2016","unstructured":"Gilling P, Reuther R, Kahokehr A, Fraundorfer M (2016) Aquablation \u2013 image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int 117:923\u2013929. https:\/\/doi.org\/10.1111\/bju.13358","journal-title":"BJU Int"},{"key":"4003_CR6","first-page":"10960","volume":"29","author":"PJ Gilling","year":"2022","unstructured":"Gilling PJ, Barber N, Bidair M et al (2022) Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol 29:10960\u201310968","journal-title":"Can J Urol"},{"key":"4003_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/JU.0000000000003483","volume":"210","author":"N Bhojani","year":"2023","unstructured":"Bhojani N, Bidair M, Kramolowsky E et al (2023) Aquablation therapy in large prostates (80\u2013150 mL) for lower urinary tract symptoms due to benign prostatic hyperplasia: final WATER II 5-year clinical trial results. J Urol 210:143\u2013153. https:\/\/doi.org\/10.1097\/JU.0000000000003483","journal-title":"J Urol"},{"key":"4003_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/CU9.0000000000000122","volume":"17","author":"DC Chen","year":"2023","unstructured":"Chen DC, Qu L, Webb H et al (2023) Aquablation in men with benign prostate hyperplasia: a systematic review and meta-analysis. Curr Urol 17:68\u201376. https:\/\/doi.org\/10.1097\/CU9.0000000000000122","journal-title":"Curr Urol"},{"key":"4003_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.euf.2026.01.006","volume":"12","author":"M Ritter","year":"2026","unstructured":"Ritter M, Stein J, Barber N et al (2026) WATER III: a prospective, partially randomized trial of Aquablation therapy versus transurethral laser enucleation of the prostate for treatment of lower urinary tract symptoms. Eur Urol Focus 12:266\u2013274. https:\/\/doi.org\/10.1016\/j.euf.2026.01.006","journal-title":"Eur Urol Focus"},{"key":"4003_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/iju.15651","volume":"32","author":"N Hinata","year":"2025","unstructured":"Hinata N, Fujisawa M, Yamaguchi R et al (2025) AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese population. Int J Urol 32:308\u2013313. https:\/\/doi.org\/10.1111\/iju.15651","journal-title":"Int J Urol"},{"key":"4003_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00345-025-06141-y","volume":"44","author":"N Lee","year":"2026","unstructured":"Lee N, Bouhadana D, Sioufi J et al (2026) Real-world outcomes of Aquablation for benign prostatic hyperplasia: a comparative analysis of the International Collaborative Aquablation Research Urology Society (ICARUS) database, WATER and WATER-II trials. World J Urol 44:146. https:\/\/doi.org\/10.1007\/s00345-025-06141-y","journal-title":"World J Urol"},{"key":"4003_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/etmj.etmj-d-25-00011","volume":"19","author":"PC Liu","year":"2025","unstructured":"Liu PC, Lin YS, Hsu CY et al (2025) Preliminary experience with the Aquablation waterjet for enlarged prostate treatment in Taiwan: a retrospective study. Tungs Med J 19:54\u201358. https:\/\/doi.org\/10.4103\/etmj.etmj-d-25-00011","journal-title":"Tungs Med J"},{"key":"4003_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00345-021-03898-w","volume":"40","author":"A El Hajj","year":"2022","unstructured":"El Hajj A, Misrai V, Nasrallah AA et al (2022) Learning curve in Aquablation: an international multicenter study. World J Urol 40:773\u2013779. https:\/\/doi.org\/10.1007\/s00345-021-03898-w","journal-title":"World J Urol"},{"key":"4003_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00345-026-06644-2","volume":"44","author":"F Passarelli","year":"2026","unstructured":"Passarelli F, Graps G, Basadonna LM et al (2026) The learning curve of waterjet ablation of the prostate: a cumulative sum analysis of surgical and functional outcomes. World J Urol 44:518. https:\/\/doi.org\/10.1007\/s00345-026-06644-2","journal-title":"World J Urol"},{"key":"4003_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11701-026-03250-7","volume":"20","author":"L Di Gianfrancesco","year":"2026","unstructured":"Di Gianfrancesco L, D\u2019Agostino D, Marino F et al (2026) The core Aquablation pentafecta: a five-domain composite definition of procedural success and learning curve validation in 300 consecutive cases. J Robot Surg 20:290. https:\/\/doi.org\/10.1007\/s11701-026-03250-7","journal-title":"J Robot Surg"},{"key":"4003_CR16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/bju.14126","volume":"121","author":"MM Desai","year":"2018","unstructured":"Desai MM, Singh A, Abhishek S et al (2018) Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients. BJU Int 121:945\u2013951. https:\/\/doi.org\/10.1111\/bju.14126","journal-title":"BJU Int"},{"key":"4003_CR17","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4:e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"key":"4003_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"4003_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4111\/icu.20200249","volume":"62","author":"M Labban","year":"2021","unstructured":"Labban M, Mansour M, Abdallah N et al (2021) Aquablation for benign prostatic obstruction: single-center technique evolution and experience. Investig Clin Urol 62:210\u2013216. https:\/\/doi.org\/10.4111\/icu.20200249","journal-title":"Investig Clin Urol"},{"key":"4003_CR20","first-page":"10610","volume":"28","author":"DS Elterman","year":"2021","unstructured":"Elterman DS, Foller S, Ubrig B et al (2021) Focal bladder neck cautery associated with low rate of post-Aquablation bleeding. Can J Urol 28:10610\u201310613","journal-title":"Can J Urol"},{"key":"4003_CR21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/bju.14990","volume":"125","author":"D Elterman","year":"2020","unstructured":"Elterman D, Bach T, Rijo E et al (2020) Transfusion rates after 800 Aquablation procedures using various haemostasis methods. BJU Int 125:568\u2013572. https:\/\/doi.org\/10.1111\/bju.14990","journal-title":"BJU Int"},{"key":"4003_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/bju.70118","volume":"137","author":"M Bitar","year":"2026","unstructured":"Bitar M, Ferreira R, Shprits S et al (2026) Aquablation for benign prostatic hyperplasia: real-world prostate size relevance and bleeding events across 6 years. BJU Int 137:480\u2013484. https:\/\/doi.org\/10.1111\/bju.70118","journal-title":"BJU Int"},{"key":"4003_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00345-024-04997-0","volume":"42","author":"J Michaelis","year":"2024","unstructured":"Michaelis J, Tr\u00e4ger M, Astheimer S et al (2024) Aquablation versus HoLEP in patients with benign prostatic hyperplasia: a comparative prospective non-randomized study. World J Urol 42:306. https:\/\/doi.org\/10.1007\/s00345-024-04997-0","journal-title":"World J Urol"},{"key":"4003_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4111\/icu.20250055","volume":"66","author":"KT Oh","year":"2025","unstructured":"Oh KT, Kim JH (2025) Aquablation versus HoLEP: propensity score matching analysis of functional outcomes and ejaculation preservation. Investig Clin Urol 66:431\u2013438. https:\/\/doi.org\/10.4111\/icu.20250055","journal-title":"Investig Clin Urol"},{"key":"4003_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00345-025-06033-1","volume":"43","author":"MHB Siqueira","year":"2025","unstructured":"Siqueira MHB, Berjaoui MB, Bhojani N et al (2025) Outcomes of Aquablation: pooled analysis from the WATER, WATER II, OPEN WATER, FRANCAIS WATER, and JAPAN PMS studies. World J Urol 43:635. https:\/\/doi.org\/10.1007\/s00345-025-06033-1","journal-title":"World J Urol"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-04003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-026-04003-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-04003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:03:19Z","timestamp":1790611399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-026-04003-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4003"],"URL":"https:\/\/doi.org\/10.1007\/s11701-026-04003-2","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"26 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived by the Institutional Review Board because of the retrospective analysis of de-identified clinical data.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Tungs\u2019 Taichung MetroHarbor Hospital (No. 115059-T; June 22, 2026).","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1034"}}